Sensus Healthcare, Inc. (SRTS)
USD 4.45
(-9.29%)
USD 4.45
(-9.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 53.72 Million USD | -5.3% |
| 2022 | 56.73 Million USD | 75.98% |
| 2021 | 32.24 Million USD | 15.1% |
| 2020 | 28 Million USD | -24.14% |
| 2019 | 36.92 Million USD | 11.05% |
| 2018 | 33.25 Million USD | 76.54% |
| 2017 | 18.83 Million USD | -0.59% |
| 2016 | 18.94 Million USD | 96.62% |
| 2015 | 9.63 Million USD | 38.79% |
| 2014 | 6.94 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 57.27 Million USD | 6.6% |
| 2024 Q2 | 58.16 Million USD | 1.55% |
| 2023 Q3 | 50.54 Million USD | -2.83% |
| 2023 Q1 | 53.39 Million USD | -5.88% |
| 2023 Q2 | 52.01 Million USD | -2.59% |
| 2023 Q4 | 53.72 Million USD | 6.29% |
| 2023 FY | 53.72 Million USD | -5.3% |
| 2022 Q3 | 54.75 Million USD | -2.82% |
| 2022 FY | 56.73 Million USD | 75.98% |
| 2022 Q1 | 53.92 Million USD | 67.27% |
| 2022 Q4 | 56.73 Million USD | 3.61% |
| 2022 Q2 | 56.34 Million USD | 4.49% |
| 2021 Q4 | 32.24 Million USD | 25.81% |
| 2021 Q3 | 25.62 Million USD | -2.79% |
| 2021 FY | 32.24 Million USD | 15.1% |
| 2021 Q2 | 26.36 Million USD | -0.45% |
| 2021 Q1 | 26.48 Million USD | -5.45% |
| 2020 Q3 | 27.72 Million USD | -6.69% |
| 2020 Q2 | 29.7 Million USD | -8.17% |
| 2020 Q4 | 28 Million USD | 1.04% |
| 2020 FY | 28 Million USD | -24.14% |
| 2020 Q1 | 32.35 Million USD | -12.38% |
| 2019 Q3 | 35.81 Million USD | -0.09% |
| 2019 Q4 | 36.92 Million USD | 3.09% |
| 2019 Q1 | 33.72 Million USD | 1.41% |
| 2019 Q2 | 35.84 Million USD | 6.31% |
| 2019 FY | 36.92 Million USD | 11.05% |
| 2018 Q3 | 32.54 Million USD | 61.74% |
| 2018 Q2 | 20.12 Million USD | -1.51% |
| 2018 FY | 33.25 Million USD | 76.54% |
| 2018 Q1 | 20.42 Million USD | 8.46% |
| 2018 Q4 | 33.25 Million USD | 2.18% |
| 2017 Q2 | 18.82 Million USD | -1.4% |
| 2017 Q4 | 18.83 Million USD | 3.93% |
| 2017 Q1 | 19.09 Million USD | 0.79% |
| 2017 FY | 18.83 Million USD | -0.59% |
| 2017 Q3 | 18.12 Million USD | -3.75% |
| 2016 FY | 18.94 Million USD | 96.62% |
| 2016 Q3 | 18.16 Million USD | -11.78% |
| 2016 Q2 | 20.58 Million USD | 106.07% |
| 2016 Q1 | 9.98 Million USD | 3.67% |
| 2016 Q4 | 18.94 Million USD | 4.33% |
| 2015 FY | 9.63 Million USD | 38.79% |
| 2015 Q4 | 9.63 Million USD | 0.0% |
| 2014 FY | 6.94 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -71.291% |
| BrainsWay Ltd. | 62.97 Million USD | 14.681% |
| Cerus Corporation | 197.74 Million USD | 72.831% |
| Envoy Medical, Inc. | 7.64 Million USD | -603.233% |
| electroCore, Inc. | 16.38 Million USD | -227.864% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -598.479% |
| IceCure Medical Ltd | 16.41 Million USD | -227.404% |
| Inogen, Inc. | 326.19 Million USD | 83.529% |
| OrthoPediatrics Corp. | 449.58 Million USD | 88.05% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -97.019% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -224.066% |
| MaxCyte, Inc. | 268.27 Million USD | 79.973% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -563.516% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1379.302% |
| Orthofix Medical Inc. | 925.31 Million USD | 94.194% |
| PAVmed Inc | 33.11 Million USD | -62.224% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 62.547% |
| RxSight, Inc. | 182.55 Million USD | 70.569% |
| Sight Sciences, Inc. | 166.65 Million USD | 67.761% |
| SI-BONE, Inc. | 230.42 Million USD | 76.684% |
| TELA Bio, Inc. | 78.04 Million USD | 31.162% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 78.672% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -400.718% |
| Acutus Medical, Inc. | 53.96 Million USD | 0.432% |
| Talis Biomedical Corporation | 98.34 Million USD | 45.366% |
| Spectral AI, Inc. | 10.69 Million USD | -402.497% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 75.428% |
| CVRx, Inc. | 115.22 Million USD | 53.374% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 8.411% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1624.643% |
| Bioventus Inc. | 810.91 Million USD | 93.374% |
| Venus Concept Inc. | 93.65 Million USD | 42.632% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -108.851% |
| LivaNova PLC | 2.42 Billion USD | 97.789% |
| 908 Devices Inc. | 202.98 Million USD | 73.531% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 93.328% |
| Nemaura Medical Inc. | 14.56 Million USD | -268.922% |
| NeuroPace, Inc. | 107.65 Million USD | 50.091% |
| LENSAR, Inc. | 69.58 Million USD | 22.789% |
| Apyx Medical Corporation | 79.24 Million USD | 32.197% |
| Cutera, Inc. | 346.29 Million USD | 84.485% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -27.873% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2888.154% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 80.148% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -25.939% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.579% |
| Axonics, Inc. | 719.92 Million USD | 92.537% |
| Outset Medical, Inc. | 313.8 Million USD | 82.879% |
| IRIDEX Corporation | 34.43 Million USD | -56.02% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 86.725% |
| IRadimed Corporation | 92.15 Million USD | 41.7% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -922.592% |
| INVO Bioscience, Inc. | 20.88 Million USD | -157.217% |
| Telesis Bio, Inc. | 70.41 Million USD | 23.695% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 65.136% |
| Varex Imaging Corporation | 1.24 Billion USD | 95.7% |
| Quipt Home Medical Corp. | 247.4 Million USD | 78.284% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -477.089% |
| Pulmonx Corporation | 178.95 Million USD | 69.977% |
| Dynatronics Corporation | 25.94 Million USD | -107.116% |
| Modular Medical, Inc. | 13.8 Million USD | -289.129% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -400.858% |
| Semler Scientific, Inc. | 78.06 Million USD | 31.177% |
| InMode Ltd. | 863.28 Million USD | 93.776% |
| Bruker Corporation | 4.24 Billion USD | 98.736% |
| Cytosorbents Corporation | 53.26 Million USD | -0.876% |
| DexCom, Inc. | 6.26 Billion USD | 99.142% |
| Align Technology, Inc. | 6.08 Billion USD | 99.117% |
| Viveve Medical, Inc. | 25.91 Million USD | -107.336% |
| ZimVie Inc. | 1.2 Billion USD | 95.543% |
| Movano Inc. | 9.42 Million USD | -470.29% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 89.204% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1379.302% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 8.411% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 94.36% |
| Profound Medical Corp. | 43.68 Million USD | -22.984% |
| Insulet Corporation | 2.58 Billion USD | 97.924% |
| enVVeno Medical Corporation | 48.63 Million USD | -10.47% |
| Surmodics, Inc. | 185.73 Million USD | 71.073% |
| iCAD, Inc. | 41.41 Million USD | -29.719% |
| Nuwellis, Inc. | 9.77 Million USD | -449.918% |
| Biotricity, Inc. | 5.94 Million USD | -804.095% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 87.596% |
| Aethlon Medical, Inc. | 8.24 Million USD | -551.554% |
| InspireMD, Inc. | 47.64 Million USD | -12.77% |
| PAVmed Inc. | 33.11 Million USD | -62.224% |
| BIOLASE, Inc. | 35.1 Million USD | -53.064% |
| Beyond Air, Inc. | 56.96 Million USD | 5.678% |
| FONAR Corporation | 214.24 Million USD | 74.923% |
| AxoGen, Inc. | 196.82 Million USD | 72.703% |
| Vivani Medical, Inc. | 45.79 Million USD | -17.316% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 80.91% |
| Inari Medical, Inc. | 674.23 Million USD | 92.031% |
| UFP Technologies, Inc. | 404.13 Million USD | 86.706% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -129.617% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -465.362% |
| Tenon Medical, Inc. | 6.34 Million USD | -746.761% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -471.139% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 48.164% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.837% |
| Sintx Technologies, Inc. | 15.36 Million USD | -249.671% |
| NanoVibronix, Inc. | 6.67 Million USD | -705.019% |
| Quanterix Corporation | 425.01 Million USD | 87.359% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -477.089% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 96.923% |
| TransMedics Group, Inc. | 706.04 Million USD | 92.39% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 14.978% |
| NeuroMetrix, Inc. | 21.42 Million USD | -150.774% |
| Hyperfine, Inc. | 94.19 Million USD | 42.964% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 80.0% |
| Biomerica, Inc. | 9.25 Million USD | -480.581% |
| Bone Biologics Corporation | 3.73 Million USD | -1337.411% |
| AVITA Medical, Inc. | 144.33 Million USD | 62.777% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1003.557% |
| Silk Road Medical, Inc | 265.3 Million USD | 79.749% |